Abiopharma

🔍 Holmes John McClain III (Executive)

Company: GATX CORP (GATX)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 731 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: A | equity_swap_involved: false | shares_owned_after: 4,192.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the Reporting Person's annual equity retainer, which is issued as restricted stock units ("RSUs") that will be settled in shares of the Issuer's common stock. Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on the date of the first annual meeting of shareholders of the Company at which directors are elected following the Grant Date, subject to the Reporting Person's continued service through such date. The Reporting Person elected to defer receipt of the shares of common stock issuable upon settlement of the RSUs under the Amended and Restated GATX Corporation Directors' Voluntary Deferred Fee Plan.